Comparative characterization of the infant gut microbiome and their maternal lineage by a multi-omics approach
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Spain
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Gut microbiome measurement Gut microbiome measurement,gut microbiome measurement
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Mothers
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Infants
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Infants (0 - 12 months old)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 43
- Group 1 sample size Number of subjects in the case (exposed) group
- 38
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 3 months prior to study recruitment
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- MaAsLin2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Supplemental data 4 and 5
Description: Differential abundance results at the phylum and genus levels for 16S rRNA gene sequencing in infants compared to mothers.
Abundance in Group 1: increased abundance in Infants
Revision editor(s): Aleru Divine
Signature 2
Source: Supplemental data 4 and 5
Description: Differential abundance results at the phylum and genus levels for 16S rRNA gene sequencing in infants compared to mothers.
Abundance in Group 1: decreased abundance in Infants
Revision editor(s): Aleru Divine
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Grandmothers
- Group 0 sample size Number of subjects in the control (unexposed) group
- 40
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Supplemental data 4 and 5
Description: Differential abundance results at the phylum and genus levels for 16S rRNA gene sequencing in infants compared to grandmothers.
Abundance in Group 1: increased abundance in Infants
Revision editor(s): Aleru Divine
Signature 2
Source: Supplemental data 4 and 5
Description: Differential abundance results at the phylum and genus levels for 16S rRNA gene sequencing in infants compared to grandmothers.
Abundance in Group 1: decreased abundance in Infants
Revision editor(s): Aleru Divine
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Mothers
- Group 0 sample size Number of subjects in the control (unexposed) group
- 43
Lab analysis
- Sequencing type
- WMS
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Supplemental data 4, 5 and 6
Description: Differential abundance results at phylum, genus and species level for Shotgun metagenomics sequencing in infants compared to mothers.
Abundance in Group 1: increased abundance in Infants
Revision editor(s): Aleru Divine
Signature 2
Source: Supplemental data 4, 5 and 6
Description: Differential abundance results at phylum, genus and species level for Shotgun metagenomics sequencing in infants compared to mothers.
Abundance in Group 1: decreased abundance in Infants
Revision editor(s): Aleru Divine
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Grandmothers
- Group 0 sample size Number of subjects in the control (unexposed) group
- 40
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Supplemental data 4, 5 and 6
Description: Differential abundance results at phylum, genus and species level for Shotgun metagenomics sequencing in infants compared to grandmothers.
Abundance in Group 1: increased abundance in Infants
Revision editor(s): Aleru Divine
Signature 2
Source: Supplemental data 4, 5 and 6
Description: Differential abundance results at phylum, genus and species level for Shotgun metagenomics sequencing in infants compared to grandmothers.
Abundance in Group 1: decreased abundance in Infants
Revision editor(s): Aleru Divine
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Mothers and Grandmothers
- Group 0 sample size Number of subjects in the control (unexposed) group
- 83
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 3 months before study recruitment
Signature 1
Source: Figure 7E
Description: Linear discriminant analysis (LDA) effect size (LEfSe) results showing the taxa enriched in the Infants – compared to the other two groups (Mothers and Grandmothers)
Abundance in Group 1: increased abundance in Infants
NCBI | Quality Control | Links |
---|---|---|
Bifidobacteriaceae | ||
Bifidobacteriales | ||
Bifidobacterium | ||
Lactobacillaceae | ||
Lactobacillus |
Revision editor(s): Aleru Divine
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Infants and Grandmothers
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mothers
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Mothers of the infants
- Group 0 sample size Number of subjects in the control (unexposed) group
- 78
- Group 1 sample size Number of subjects in the case (exposed) group
- 43
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 7E
Description: Linear discriminant analysis (LDA) effect size (LEfSe) results showing the taxa enriched in the Mothers – compared to the other two groups (Infants and Grandmothers)
Abundance in Group 1: increased abundance in Mothers
NCBI | Quality Control | Links |
---|---|---|
Clostridia | ||
Eubacteriales | ||
Bacillota | ||
Blautia | ||
Dialister | ||
Holdemania | ||
Sutterella | ||
Clostridium IIIClostridium III |
Revision editor(s): Aleru Divine
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Infants and Mothers
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Grandmothers
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Grandmothers of the infants.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 81
- Group 1 sample size Number of subjects in the case (exposed) group
- 40
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 7E
Description: Linear discriminant analysis (LDA) effect size (LEfSe) results showing the taxa enriched in the Grandmothers – compared to the other two groups (Infants and Mothers)
Abundance in Group 1: increased abundance in Grandmothers
Revision editor(s): Aleru Divine